Soon after birth, a baby in the United States is tested for sickle cell disease, the often-devastating genetic blood disorder affecting more than 100,000 Americans and 20 million of people worldwide. If positive, that newborn typically begins a course of treatment that can greatly prolong life and help stave off complications of the disease. But in sub-Saharan Africa, where the majority of sickle cell disease cases can be found—and where resources are scant—newborn screening programs are virtua...

Author Aid Research Writing in the Sciences The free course is designed for researchers in developing countries, particularly those working in a scientific field (life sciences / natural sciences / other related fields). It is suitable for early career researchers, or those with limited experience in publishing papers in reputable peer-reviewed journals. Starts 4 September Enrollment open now. https://www.authoraid.info/en/news/details/1316/ ------------------------------------...

Sickle cell disease (SCD) is a neglected health problem in sub-Saharan Africa (SSA) where more than half of affected individuals die before their 5th birthday due to preventable complications. In response, a “Sickle-cell anemia” resolution (WHA59.20) was passed at the 59th World Health Assembly in 2006, urging Member States and the WHO Director-General to promote and support actions to address SCD. That was followed in 2010 with adoption by the WHO Regional Office for Africa of “Sickle-cell...

A recipient of the FIOCRUZ scholarship - Uche Ndidi defends his PhD thesis on "Effect of Carboxymethyl lysine, anadvanced glycation end product, on sickle cell disease” at the INSTITUTO GONÇALO MONIZ-FUNDAÇÁO OSWALDO CRUZ (IGM-FIOCRUZ), Bahia, Brazil in the Curso de Pós-Graduação em Biotecnologia em Saúde e Medicina Investigativa (PgBSMI) (Postgraduate course in Biotechnology in health and Investigative Medicine) on June 19, 2018.